As COVID-19 sweeps across the world, more and more people find themselves isolated at home, unable to go to the doctor’s office or hospital for their regular checkups. See how Diabetes:M can help in this situation.
Sirma announces the release of new functionality in its specialized medical application Diabetes:M, which helps doctors monitor their patients with diabetes remotely, and prevent them from unnecessary exposure to potential threats when going out for regular checks.
Diabetes:M provides a special functionality to help in this situation – the Diabetes:M Monitor tool. It allows doctors, clinicians, caregivers, or other medical experts to have their patient’s information ready and available in real-time. That means you monitor all your diabetic patients remotely in one place in this time of crisis and keep track of how they are doing in great detail. It also provides a fantastic range of statistical information, recurring problems, and other analytical tools.
To get access to the patients’ data, first, the medical specialists have to be registered in the system. After registration, the doctor will receive an email with a clinician’s code and additional instructions, which they can send to their patients. If the patients are already using the app, the doctor can send them a request to share their data directly from the interface.
Due to the Covid-19 pandemic, Sirma releases all of Diabetes:M’s Premium functionality for FREE until June 16th, 2020.
Diabetes:M Monitor is free for clinicians, but normally patients have to be Premium subscription plan users to unlock this feature. Sirma releases all of Diabetes:M’s Premium functionality for FREE until June 16th, 2020 in order to help doctors and their diabetes patients. The period can be extended, depending on the development of the situation.
To activate it, the users have to enter a special code STAYHOME in the web version of the app. The company created a pandemic response page, which will help people activate this free usage, and provide other useful information.
“The COVID-19 pandemic is wreaking havoc in our lives, with millions under quarantine or in isolation across the world. For medical teams monitoring patients with diabetes, this could cause a particular problem, as regular doctor’s appointments and hospital visits are canceled for safety reasons. Our solution enables daily monitoring of the diabetic patients remotely in one place in this time of crisis, and to keep track of how they are doing in great detail.” said Ivan Yordanov, Marketing Manager
For full information about what Diabetes:M Monitor is and how to work with it, please visit our detailed guide.
Diabetes:M was first published in April 2013. It was developed by people with diabetes to meet the needs of people who want to manage all aspects of their condition. Users can track, analyze, review, and export data in great detail. Today Diabetes:M is an award-winning established tool, with over 500 000 installations and more than 50 000 active users. The application is well known to medical professionals, with many diabetes specialists recommending it to their patients.
Get it on iTunes
Download on Google Play